Abstract
Objective To analyze the clinical data of patients with hilar cholangiocarcinoma (HCCA), and to compare the therapeutic effects of different methods on treating these patients. Methods The clinical data of 101 patients with HCCA in China-Japan Union Hospital of Jilin University were analyzed. Results The overall 1-year and 2-year survival rates in the radical operation group were 95.5% and 40.9%, respectively. There was a significant difference between the radical operation group and the palliative resection group (P 0.05). Conclusions Radical HCCA resection is still the best and the first choice treatment for patients with HCCA. The therapeutic effects of radical operation were much better than those of palliative resection, biliary stent, PTCD and open abdominal biliary drainage. Key words: Hilar cholangiocarcinoma (HCCA); Radical operation; Palliative resection; PTCD; Biliary stent
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
